Clinical Trials Browser

Phase NA × OTHER × Oligometastatic Lung Adenocarcinoma × Clear all

NCT02450591 2018-05-21

Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations

Phase NA Completed

4 enrolled 7 charts

Oligometastatic Lung Adenocarcinoma